DLL4 and idiopathic pulmonary arterial hypertension: In PAECs from IPAH patients compared to failed donor controls, expression of α-SMA (ACTA2), a mesenchymal marker, was significantly increased and this effect was significantly abrogated by immobilized DLL4 as assessed by immunofluorescence staining (Figure 5D).